日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China

基因治疗产品（GTP）从监管审批到市场准入的路径：美国、欧盟五国、日本和中国的综合综述

期刊:Regenerative Therapy
影响因子:
doi:10.1016/j.reth.2026.101102
Shi, Junnan; Hu, Hao; Ung, Carolina Oi Lam
基因治疗
发表日期：2026
文献求助 收藏

The clinical quality management system of advanced therapy medicinal products in the hospital setting: A scoping review

医院环境下先进疗法药品临床质量管理体系：范围界定综述

期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2025.101485
Shi, Junnan; Yang, Jinagya; Zheng, Yu; Wong, Phyllis Hio Hong; Hu, Hao; Ung, Carolina Oi Lam
发表日期：2025
文献求助 收藏

CSAD inhibits excessive inflammation during viral infections through the NF-κB signaling pathway.

CSAD通过NF-κB信号通路抑制病毒感染期间的过度炎症。

期刊:Journal of Virology
影响因子:3.8
doi:10.1128/jvi.00706-25
Zhang Yufan, Yang Xiaotian, Chen Yun, Shi Junnan, Zhou Kai, Zhu Li, Wang Jing, Jiang Wei, Zhao Dahui, Gan Lipeng, Ren Sanguo, Fang Min
炎症/感染
Immunology/Inflammation
炎症
发表日期：2025
文献求助 收藏

Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control

对中国肝癌政策和规划的批判性分析：对国际肝癌防控的启示

期刊:
影响因子:
doi:10.1186/s41256-025-00450-w
Chen, Xianwen; Shi, Junnan; Xue, Yan; Lai, Yunfeng; Song, Menghuan; Ung, Carolina Oi Lam; Hu, Hao
肿瘤
肝癌
肿瘤免疫
发表日期：2025
文献求助 收藏

The role of hospital pharmacists in supporting the appropriate and safe use of CGT/ATMPs: a scoping review of current insights

医院药剂师在支持合理安全地使用临床药物/先进治疗药物方面的作用：对现有见解的范围界定综述

期刊:BMC Health Services Research
影响因子:
doi:10.1186/s12913-024-12026-4
Shi, Junnan; Chen, Xianwen; Hu, Hao; Ung, Carolina Oi Lam
发表日期：2025
文献求助 收藏

FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner

FTO 通过以 HuR 依赖的 m6A 方式激活 P53-P21/Nrf2 抑制铁死亡，从而减轻阿霉素引起的心脏毒性

期刊:Redox Biology
影响因子:10.7
doi:10.1016/j.redox.2024.103067
Yunfan Yang, Jiajun Ren, Jifeng Zhang, Henghe Shi, Junnan Wang, Youyou Yan
细胞生物学
发表日期：2024
文献求助 收藏

Implementation of the Macao dementia policy: a scoping review for the way forward

澳门痴呆症政策实施情况：未来发展方向的范围界定审查

期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2024.1400172
Tang, Pou Kuan; Cen, Zhifeng; Zheng, Yu; Shi, Junnan; Hu, Hao; Ung, Carolina Oi Lam
发表日期：2024
文献求助 收藏

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design

对中药治疗非酒精性脂肪性肝炎（NASH）的随机对照试验进行系统分析：对未来药物研发和试验设计的启示

期刊:Chinese Medicine
影响因子:5.7
doi:10.1186/s13020-023-00761-5
Chen, Xianwen; Shi, Junnan; Lai, Yunfeng; Xue, Yan; Ung, Carolina Oi Lam; Hu, Hao
肝炎
发表日期：2023
文献求助 收藏

Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials

传统中医药治疗癌症相关疲乏的疗效和安全性：随机对照试验的系统性文献综述

期刊:Chinese Medicine
影响因子:5.7
doi:10.1186/s13020-023-00849-y
Yang, Jingya; Li, Yuxiao; Chau, Chi Ian; Shi, Junnan; Chen, Xianwen; Hu, Hao; Ung, Carolina Oi Lam
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Benchmarking Drug Regulatory Systems for Capacity Building: An Integrative Review of Tools, Practice, and Recommendations

药品监管体系能力建设基准分析：工具、实践和建议的综合评估

期刊:International Journal of Health Policy and Management
影响因子:5.1
doi:10.34172/ijhpm.2023.8100
Shi, Junnan; Chen, Xianwen; Hu, Hao; Ung, Carolina Oi Lam
发表日期：2023
文献求助 收藏